AUS
NZ
UK
CA
USA
IND
Healt
ASX 200 Update: Telix Pharmaceuticals Sector Focus
April 08, 2026 02:44 PM AEST| By SamTelix Pharmaceuticals operates within the ASX 200 biotechnology sector, focusing on radiopharmaceutical development and contributing to healthcare market participation.
Mesoblast Seeks ASX 200 Quotation for New Shares
April 08, 2026 12:36 PM AEST| By SamMesoblast advances share quotation within the ASX 200 framework, reflecting capital structure adjustments and ongoing participation in the biotechnology sector.
Telix ASX 200 Healthcare Revenue Activity Update
April 07, 2026 02:28 PM AEST| By SamTelix operates within the healthcare sector, with radiopharmaceutical development and revenue activity reflecting ongoing innovation across ASX 200 and ASX 300 market segments.
ASX 20: What US tariffs mean for CSL and Mayne Pharma shares
April 07, 2026 02:23 PM AEST| By SamCSL and Mayne Pharma assess impact of US pharmaceutical tariffs, with both expecting limited operational disruption.
Beamtree (ASX:BMT) All Ordinaries AI Healthcare Sector Focus
April 07, 2026 01:50 PM AEST| By SamBeamtree operates in the healthcare technology sector, where AI-driven platforms and data systems support evolving medical services within the All Ordinaries market landscape.
Ramsay’s Big Shift: What’s Changing at RHC Now?
April 07, 2026 10:53 AM AEST| By SamRamsay Health Care’s strategic shift toward Australian operations highlights a renewed focus on efficiency, cost management and operational clarity, reshaping how the company is positioned within the evolving healthcare landscape.
ASX All Ordinaries Biotech Stock Update on Starpharma
April 07, 2026 09:48 AM AEST| By SamStarpharma’s share issuance highlights capital management within the biotechnology sector, reflecting research-driven operations and participation across All Ordinaries.
Can Lumos (ASX:LDX) Redefine Rapid Infection Testing?
April 02, 2026 10:20 PM AEDT| By SamLumos (ASX:LDX) advances US expansion with FebriDx, enhancing rapid infection diagnosis and supporting efficient clinical decisions across healthcare settings.
Is Vitura Health Entering a New Growth Phase?
April 02, 2026 08:27 PM AEDT| By SamVitura Health’s leadership change highlights its evolving digital healthcare strategy, focusing on specialised treatments, patient access, and operational transformation within the Australian healthcare sector.
Is CSL’s Buy-Back Strategy Redefining Its Market Narrative?
April 02, 2026 06:56 PM AEDT| By SamCSL’s ongoing buy-back strategy highlights capital discipline while balancing growth investments, margin recovery, and structural changes shaping its evolving market narrative.
Imagion Biosystems Clarifies Filing, Reviews Compliance on All Ords
April 02, 2026 05:23 PM AEDT| By SamImagion Biosystems addresses filing delay aligned with the all ordinaries, covering compliance updates, convertible note repayment, and ongoing progress in MagSense imaging technology development.
Is 4DMedical Expanding Capital Base Amid All Ords Index Move?
April 02, 2026 04:36 PM AEDT| By Sam4DMedical progresses share quotation aligned with the all ordinaries, reflecting capital expansion and ongoing development of advanced respiratory imaging solutions in healthcare technology.
Lumos Diagnostics Jumps on US Clearance Amid Iran-US War?
April 02, 2026 04:22 PM AEDT| By SamLumos Diagnostics progresses FebriDx deployment aligned with the all ordinaries, covering regulatory milestones, distribution strategy, reimbursement pathways, and manufacturing expansion in healthcare diagnostics.
All Ordinaries Healthcare Stock Share Issue Draws Focus
April 02, 2026 03:37 PM AEDT| By SamAll Ordinaries healthcare activity highlights Racura Oncology share quotation process, reflecting capital structure developments and biotechnology sector participation across the market.
ASX 200 Sigma Healthcare Expansion Drives Market Focus
April 02, 2026 02:34 PM AEDT| By SamSigma Healthcare reflects pharmacy distribution and retail activity, highlighting healthcare sector integration and supply chain operations within the ASX 200 market.
These ASX 200 Healthcare Shares Are Turning Heads Today
April 02, 2026 12:42 PM AEDT| By SamASX healthcare sector activity reflects medical innovation, operational frameworks, and sector participation across indices, highlighting the role of healthcare companies in broader market dynamics.
Why ASX 200 Healthcare Shares Are Back in Focus After Sector Rout
April 02, 2026 12:11 PM AEDT| By SamASX 200 healthcare shares face pressure amid sector decline, with select companies drawing attention as valuations reset.
Can Healius (ASX:HLS) Redefine Diagnostics Growth?
April 01, 2026 09:23 PM AEDT| By SamHealius explores growth in diagnostics through strong healthcare demand, digital innovation, and expanding service networks across Australia’s evolving medical landscape.
Is This ASX 200 Healthcare Share Gearing Up for Growth?
April 01, 2026 05:10 PM AEDT| By SamHealthcare innovation continues to reshape market dynamics, with emerging companies gaining attention through clinical progress, global demand, and advanced treatment technologies within Australia’s evolving equities landscape.
ASX 20: CSL Updates Market on Ongoing Share Buy-Back Strategy
April 01, 2026 03:56 PM AEDT| By SamCSL continues its share buy-back program, highlighting strong capital management and reinforcing its position in the australian stock market.
Advertise your brand on Kalkine Media